12 filings
8-K
RETA
Reata Pharmaceuticals Inc
20 Dec 19
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:05pm
8-K
RETA
Reata Pharmaceuticals Inc
14 Nov 19
Entry into a Material Definitive Agreement
5:00pm
8-K
RETA
Reata Pharmaceuticals Inc
12 Nov 19
Reata Pharmaceuticals, Inc. Announces Third Quarter 2019 Financial Results and an Update on Development Programs
6:50am
8-K
RETA
Reata Pharmaceuticals Inc
16 Oct 19
Entry into a Material Definitive Agreement
4:23pm
8-K
RETA
Reata Pharmaceuticals Inc
15 Oct 19
Reata announces positive Topline results from the moxie Registrational trial of omaveloxolone in patients with friedreich’s ataxia
6:45am
8-K
tcow9x 6zaa6he1bbdhq
10 Oct 19
Entry into a Material Definitive Agreement
6:51am
8-K
tpuy0140lceec xud
29 Aug 19
Reata Appoints Manmeet s. Soni as Chief Financial Officer; Jason D. wilson to assume new role AS EVP, Operations
12:00am
8-K
6l2txg avxik6w1
22 Aug 19
Entry into a Material Definitive Agreement
4:54pm
8-K
opz7mzzef3nutc2s50y
8 Aug 19
Reata Pharmaceuticals, Inc. Announces Second Quarter 2019 Financial Results and an Update on Development Programs
6:44am
8-K
3n0fv3sk0y3rvxc
13 Jun 19
Departure of Directors or Certain Officers
4:05pm
8-K
3ui4w
9 May 19
Reata PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS AND AN UPDATE ON DEVELOPMENT PROGRAMS
6:49am
8-K
7fmgt80xkd6ol0tqe
28 Feb 19
Reata PHARMACEUTICALS, Inc. annouNces fourth quarter and full year 2018 financials and operating results
6:50am
- Prev
- 1
- Next